NeuBase Therapeutics, Inc. – ‘10-K’ for 9/30/13 – ‘EXCEL’

On:  Friday, 12/27/13, at 4:06pm ET   ·   For:  9/30/13   ·   Accession #:  1387131-13-4795   ·   File #:  1-35963

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    554K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
48: R1          Document and Entity Information                     HTML     44K 
35: R2          Balance Sheets                                      HTML     79K 
32: R3          Balance Sheets (Parenthetical)                      HTML     37K 
14: R4          Statements of Operations                            HTML     84K 
34: R5          Statements of Operations (Parenthetical)            HTML     18K 
24: R6          Statements of Stockholders' Equity                  HTML     99K 
42: R7          Statements of Cash Flows                            HTML    136K 
25: R8          Description of Business                             HTML     19K 
27: R9          Summary of Significant Accounting Policies          HTML     49K 
15: R10         Patent Costs                                        HTML     20K 
26: R11         Notes Payable                                       HTML     21K 
41: R12         Derivative Liability and Fair Value Measurements    HTML     32K 
38: R13         Capital Stock                                       HTML     43K 
33: R14         Common Stock Warrants                               HTML     76K 
45: R15         Common Stock Options                                HTML     38K 
40: R16         Commitments and Contingencies                       HTML     21K 
12: R17         Subsequent Events                                   HTML     19K 
17: R18         Summary of Significant Accounting Policies          HTML     92K 
                (Policies)                                                       
44: R19         Summary of Significant Accounting Policies          HTML     31K 
                (Tables)                                                         
47: R20         Common Stock Warrants (Tables)                      HTML     66K 
49: R21         Common Stock Options (Tables)                       HTML     32K 
46: R22         Description of Business (Details Narrative)         HTML     21K 
37: R23         Summary of Significant Accounting Policies          HTML     37K 
                (Details Narrative)                                              
16: R24         Summary of Significant Accounting Policies          HTML     28K 
                (Details)                                                        
22: R25         Summary of Significant Accounting Policies          HTML     24K 
                (Details1)                                                       
19: R26         Patent Costs (Details Narrative)                    HTML     25K 
18: R27         Notes Payable (Details Narrative)                   HTML     31K 
28: R28         Derivative Liability and Fair Value Measurements    HTML    112K 
                (Details Narrative)                                              
36: R29         Capital Stock (Details Narrative)                   HTML    130K 
39: R30         Common Stock Warrants (Details Narrative)           HTML    109K 
21: R31         Common Stock Warrants (Details)                     HTML     67K 
29: R32         Common Stock Options (Details Narrative)            HTML     57K 
43: R33         Common Stock Options (Details)                      HTML     44K 
20: R34         Subsequent Events (Details Narrative)               HTML     41K 
31: XML         IDEA XML File -- Filing Summary                      XML     67K 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX    121K 
30: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    631K 
 6: EX-101.INS  XBRL Instance -- ohrp-20130930                       XML   1.26M 
 8: EX-101.CAL  XBRL Calculations -- ohrp-20130930_cal               XML     99K 
 9: EX-101.DEF  XBRL Definitions -- ohrp-20130930_def                XML    321K 
10: EX-101.LAB  XBRL Labels -- ohrp-20130930_lab                     XML    689K 
11: EX-101.PRE  XBRL Presentations -- ohrp-20130930_pre              XML    517K 
 7: EX-101.SCH  XBRL Schema -- ohrp-20130930                         XSD    113K 
23: ZIP         XBRL Zipped Folder -- 0001387131-13-004795-xbrl      Zip     91K 

‘EXCEL’   —   IDEA Workbook of Financial Reports (.xls)

This is an IDEA Workbook.

	Download this Microsoft® Excel® .xls workbook
Web Archive:	This document is a Single File Web Page, also known as         a Web Archive file.  To view this Workbook file format,         your browser or editor must support Web Archive files.